Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K ؉ ) channels. Studies have also found reduced levels of the ␣ isoform of PKC in brains and fibroblasts of AD patients. Since PKC is known to regulate ion channels, we studied K ؉ channel activity in fibroblasts from AD patients in the presence of (2S, 5S)-8-(1-decynyl)benzolactam (BL), a novel activator of PKC with improved selectivity for the ␣, ␤, and ␥ isoforms. We present evidence for restoration of normal K ؉ channel function, as measured by TEA-induced [Ca 2؉ ] i elevations, due to activation of PKC by BL. Representative patch-clamp data further substantiate the effect of BL on restoration of 113pS K ؉ channel activity. Immunoblotting analyses using an ␣-isozyme-specific PKC antibody confirm that BL-treated fibroblasts of AD patients show increased PKC activation. The present study suggests that PKC activator-based restoration of K ؉ channels may offer another approach to the investigation of AD pathophysiology, which in turn could lead to the development of a useful model for AD therapeutics. 1998 Academic Press
INTRODUCTION
The use of peripheral tissues from Alzheimer's disease (AD) patients and animal neuronal cells permitted the identification of a number of cellular/molecular alterations that may be the reflection of comparable processes in the AD brain and thus, of pathophysiological relevance (Baker et al., 1988; Scott, 1993; Huang, 1994; Scheuner et al., 1996; Etcheberrigaray & Alkon, 1997; Gasparini et al., 1997) . Alterations of potassium channel function have been identified in fibroblasts (Etcheberrigaray et al., 1993) and in blood cells (Bondy et al., 1996) obtained from AD patients. In addition, it was shown that ␤-amyloid, widely accepted as a major player in AD pathophysiology (Gandy & Greengard, 1994; Selkoe, 1994; Yankner, 1996) , was capable of inducing an AD-like K ϩ channel alteration in control fibroblasts (Etcheberrigaray et al., 1994) . Similar or comparable effects of ␤-amyloid on K ϩ channels have been reported in neurons from laboratory animals (Good et al., 1996 ; also for a review see Fraser et al., 1997) . An earlier observation of hippocampal alterations of apamin-sensitive K ϩ channels in AD brains (as measured by apamin binding) provides additional support for the suggestion that K ϩ channels may be pathophysiologically relevant in AD (Ikeda et al., 1991) . Furthermore, protein kinase C (PKC) exhibits parallel changes in peripheral and brain tissues of AD patients. The levels and/or activity of this enzyme(s) were reduced in brains and fibroblasts from AD patients (Cole et al., 1988; Van Huynh et al., 1989; Govoni et al., 1993; Wang et al., 1994) . Studies using immuno-
